Lakefront Biotherapeutics (LKFT) Goodwill & Intangibles (2014 - 2026)

Lakefront Biotherapeutics (LKFT) has 13 years of Goodwill & Intangibles data on file, last reported at $873376.3 in Q1 2026.

• Goodwill & Intangibles for Q1 2026 came in at $873376.3, down 99.63% year-over-year; the trailing twelve-month figure through Mar 2026 was $873376.3 (down 99.63% YoY), and the FY2025 annual result was $987108.9, down 99.61% from the prior year.
• Goodwill & Intangibles declined to $873376.3 in Q1 2026 per LKFT's latest filing, from $987108.9 in the prior quarter.
• Over five years, Goodwill & Intangibles peaked at $266.8 million in Q3 2024 and troughed at $873376.3 in Q1 2026.
• A 5-year average of $147.2 million and a median of $212.6 million in 2024 frame the typical range for Goodwill & Intangibles.
• The sharpest annual moves came in 2022 and 2026: Goodwill & Intangibles surged 1059.74% in 2022, then slumped 99.63% in 2026.
• A 5-year view of Goodwill & Intangibles shows it stood at $55.7 million in 2022, then jumped by 117.72% to $121.3 million in 2023, then jumped by 106.93% to $251.0 million in 2024, then slumped by 99.61% to $987108.9 in 2025, then decreased by 11.52% to $873376.3 in 2026.
• Business Quant data shows LKFT's Goodwill & Intangibles at $873376.3 in Q1 2026, $987108.9 in Q4 2025, and $8.7 million in Q3 2025.